NUCEIVA

prabotulinumtoxinA · Evolus, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for NUCEIVA, covering 2024-05-28 to 2025-08-05. Get the full timeline:

Most recent: Clinical Trial Update: Non Interventional Safety Study of NUCEIVA for the Treatment of Moderate-to-Severe Glabellar Lines